Código QR (código de barras bidimensional)

Preclinical and Toxicology Studies of 1263W94, a Potent and Selective Inhibitor of Human Cytomegalovirus Replication

1263W94 is a novel benzimidazole compound being developed for treatment of human cytomegalovirus infection. No adverse pharmacological effects were demonstrated in safety pharmacology studies with 1263W94. The minimal-effect dose in a 1-month rat study was 100 mg/kg/day, and the no-effect dose in a...

ver descrição completa

Na minha lista:
Publicado no:Antimicrob Agents Chemother
Principais autores: Koszalka, George W., Johnson, Nelson W., Good, Steven S., Boyd, Leslie, Chamberlain, Stanley C., Townsend, Leroy B., Drach, John C., Biron, Karen K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2002
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127362/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12121907/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.8.2373-2380.2002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados